Lanreotide vs Melanotan II
Overview
Lanreotide is primarily a hormonal peptide, while Melanotan II is used for cosmetic & skin.
This page compares Lanreotide and Melanotan II across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| Lanreotide | Melanotan II | |
|---|---|---|
| Category | Hormonal | Cosmetic & Skin |
| Regulatory status (US) | FDA approved | Compounding (Rx) — Apr 2026 |
| Typical dosage | 60-120 mg | 250-500 mcg |
| Frequency | every 4 weeks | as needed |
| Reported benefits | suppression of excess growth hormone and IGF-1 in acromegaly, improved progression-free survival in GEP-NETs, reduction of carcinoid syndrome symptoms, inhibition of multiple GI and pancreatic hormones | Skin tanning without UV exposure, increased libido, potential appetite suppression |
| Reported side effects | diarrhea, cholelithiasis, abdominal pain, hyperglycemia, bradycardia, injection site reactions, nausea, hypertension, headache, thyroid function decreases | Nausea, facial flushing, darkening of moles, potential cardiovascular effects |
Key differences
Primary use. Lanreotide is categorised under Hormonal, while Melanotan II falls under Cosmetic & Skin. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.
Regulatory status. Lanreotide: FDA-approved. Melanotan II: not FDA-approved; compounding permitted with a prescription as of April 2026.
Dosing. Lanreotide is typically dosed at 60-120 mg (every 4 weeks). Melanotan II is typically dosed at 250-500 mcg (as needed).
Can you stack them?
Some protocols combine peptides, but stacking Lanreotide and Melanotan II has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between Lanreotide and Melanotan II?
- Lanreotide is primarily a hormonal peptide, while Melanotan II is used for cosmetic & skin. Lanreotide is FDA-approved for one or more indications, whereas Melanotan II is not FDA-approved; compounding permitted with a prescription (as of April 2026).
- What is Lanreotide used for?
- FDA-approved long-acting somatostatin analog for acromegaly, GEP-NETs, and carcinoid syndrome.
- What is Melanotan II used for?
- Tanning, libido.
- Can you take Lanreotide and Melanotan II together?
- Some users combine peptides within a single protocol, but stacking Lanreotide and Melanotan II has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is Lanreotide or Melanotan II FDA-approved?
- Lanreotide is FDA-approved for one or more indications. Melanotan II is not FDA-approved; compounding permitted with a prescription (as of April 2026).
Read the full articles
- Lanreotide — full monograph: mechanism, research, dosing & references
- Melanotan II — full monograph: mechanism, research, dosing & references